These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21453792)

  • 1. A comparison of two worlds: How does Bayes hold up to the status quo for the analysis of clinical trials?
    Pressman AR; Avins AL; Hubbard A; Satariano WA
    Contemp Clin Trials; 2011 Jul; 32(4):561-8. PubMed ID: 21453792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Bayesian and frequentist group-sequential clinical trial designs.
    Stallard N; Todd S; Ryan EG; Gates S
    BMC Med Res Methodol; 2020 Jan; 20(1):4. PubMed ID: 31910813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive designs in critical care trials: a simulation study.
    Li W; Cornelius V; Finfer S; Venkatesh B; Billot L
    BMC Med Res Methodol; 2023 Oct; 23(1):236. PubMed ID: 37853343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bayesian sequential design using alpha spending function to control type I error.
    Zhu H; Yu Q
    Stat Methods Med Res; 2017 Oct; 26(5):2184-2196. PubMed ID: 26187736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical rules for safety monitoring in clinical trials.
    Martens MJ; Logan BR
    Clin Trials; 2024 Apr; 21(2):152-161. PubMed ID: 37877375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
    Ryan EG; Brock K; Gates S; Slade D
    BMC Med Res Methodol; 2020 Jun; 20(1):150. PubMed ID: 32522284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stopping a clinical trial early: frequentist and Bayesian approaches applied to a CALGB trial in non-small-cell lung cancer.
    George SL; Li C; Berry DA; Green MR
    Stat Med; 1994 Jul 15-30; 13(13-14):1313-27. PubMed ID: 7973212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upstrapping to determine futility: predicting future outcomes nonparametrically from past data.
    Wild JL; Ginde AA; Lindsell CJ; Kaizer AM
    Trials; 2024 May; 25(1):312. PubMed ID: 38725072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Bayesian and frequentist monitoring boundaries motivated by the Multiplatform Randomized Clinical Trial.
    Joo J; Leifer ES; Proschan MA; Troendle JF; Reynolds HR; Hade EA; Lawler PR; Kim DY; Geller NL
    Clin Trials; 2024 Dec; 21(6):701-709. PubMed ID: 38760932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes.
    Moatti M; Chevret S; Zohar S; Rosenberger WF
    Methods Inf Med; 2016; 55(1):4-13. PubMed ID: 26404511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian evaluation of group sequential clinical trial designs.
    Emerson SS; Kittelson JM; Gillen DL
    Stat Med; 2007 Mar; 26(7):1431-49. PubMed ID: 17066402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Bayesian with group sequential methods for monitoring clinical trials.
    Freedman LS; Spiegelhalter DJ
    Control Clin Trials; 1989 Dec; 10(4):357-67. PubMed ID: 2691203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian-frequentist two-stage single-arm phase II clinical trial design.
    Dong G; Shih WJ; Moore D; Quan H; Marcella S
    Stat Med; 2012 Aug; 31(19):2055-67. PubMed ID: 22415966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An additive boundary for group sequential designs with connection to conditional error.
    Xi D; Gallo P
    Stat Med; 2019 Oct; 38(23):4656-4669. PubMed ID: 31338847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches.
    Zaslavsky BG; Scott J
    J Biopharm Stat; 2012; 22(4):819-35. PubMed ID: 22651117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian designs and the control of frequentist characteristics: a practical solution.
    Ventz S; Trippa L
    Biometrics; 2015 Mar; 71(1):218-226. PubMed ID: 25196832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian predictive approach to interim monitoring in clinical trials.
    Dmitrienko A; Wang MD
    Stat Med; 2006 Jul; 25(13):2178-95. PubMed ID: 16007570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of randomised controlled trials with adaptive and traditional group sequential designs - applications in cardiovascular clinical trials.
    Zhang J; Saju C
    BMC Med Res Methodol; 2023 Sep; 23(1):200. PubMed ID: 37679710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian survival analysis in clinical trials: What methods are used in practice?
    Brard C; Le Teuff G; Le Deley MC; Hampson LV
    Clin Trials; 2017 Feb; 14(1):78-87. PubMed ID: 27729499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.